Loading clinical trials...
Loading clinical trials...
Substrate Targeted Ablation Using the FlexAbility™ Ablation Catheter System for the Reduction of Ventricular Tachycardia (STAR-VT) - G130132
Conditions
Interventions
Cardiac catheter ablation with ICD/CRT-D
Locations
38
United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
USC University Hospital
Los Angeles, California, United States
Ronald Reagan UCLA Medical Center
Los Angeles, California, United States
University of California at San Diego (UCSD) Medical Center
San Diego, California, United States
University of California at San Francisco
San Francisco, California, United States
Washington Hospital Center
Washington D.C., District of Columbia, United States
Start Date
November 1, 2014
Primary Completion Date
July 25, 2016
Completion Date
July 25, 2016
Last Updated
February 12, 2019
NCT02274168
NCT03734562
NCT02584595
Lead Sponsor
Abbott Medical Devices
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions